(Q34446588)

English

Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

inflammatory bowel diseases

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Sparrow MP

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Hande SA

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Friedman S

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Lim WC

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Reddy SI

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Cao D

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Hanauer SB

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

441-446

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02583.X

21 January 2018

Measurement of thiopurine methyltransferase activity and azathioprine metabolites in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02583.X

21 January 2018

Low-dose allopurinol plus azathioprine/cyclosporin/prednisolone, a novel immunosuppressive regimen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02583.X

21 January 2018

Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02583.X

21 January 2018

Human thiopurine S-methyltransferase activity in uremia and after renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02583.X

21 January 2018

Progress towards the discovery of xanthine oxidase inhibitors.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02583.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2005.02583.X

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34446588&oldid=1605090136"